Novira Therapeutics' Series A - III Round

Novira Therapeutics raised a round of funding on February 11, 2014.

Novira Therapeutics is an antiviral drug discovery company that is focused on the discovery of first-in-class antiviral therapeutics for the treatment of chronic HBV and HIV infections, two global dis…

Articles about Novira Therapeutics' Series A - III Round: